I'm not saying they are waiting on severe results "for mild to moderate", I just don't believe that the data from a n=87 is overwhelming enough for immediate approval in the m/m population. They're going to approve LL as S/C if they're going to approve it at all, that's my argument. That's where the binary endpoint alive/dead carries far more weight than the NEWS data points if indeed Leronlimab is saving those lives.